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ABSTRACT 22 
 23 
The present report describes a real-time PCR-based procedure to reliably determine the quantity of 24 
Leishmania amastigotes in relation to the amount of host tissue in histological skin sections from 25 
canine and equine cases of cutaneous leishmaniasis. The novel diagnostic Leishmania-PCR has a 26 
detection limit of <0.02 amastigotes per µg tissue, which corresponds well to the detection limit of 27 
immunohistochemistry and is far beyond that of conventional histology. Our results emphasise the 28 
importance of PCR to complement routine histology of cutaneous leishmaniasis cases, particularly in 29 
laboratories in which no immunohistochemical assay is available. 30 
 31 
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 41 
Leishmaniasis is a disease caused by different species of protists of the genus Leishmania and is 42 
transmitted by sandflies. The species Leishmania infantum is an important causative agent of canine 43 
leishmaniasis [1-3]. This disease is associated with a wide range of symptoms including skin lesions, 44 
which are present in most clinical cases. Histology most commonly reveals a granulomatous band-like 45 
infiltrate in the superficial dermis, a granulomatous perifolliculitis and/or interstitial and perivascular 46 
dermatitis [4]. 47 
A few years ago, some cases of confirmed non-imported equine [5], and one case of bovine [6], 48 
cutaneous leishmaniasis were detected in Switzerland and Germany. Here, disease symptoms were 49 
mostly temporary, and included nodules of varying size sometimes covered by an eroded or ulcerated 50 
epidermis. Histologically, the lesions were characterized by an interstitial to diffuse or a nodular 51 
infiltrate composed of macrophages, as well as scattered lymphocytes, plasma cells, multinucleated 52 
giant cells and neutrophils. Surprisingly, phylogenetic analyses of sequence data for the first internal 53 
transcribed spacer (ITS-1) of nuclear ribosomal DNA from parasites from these cases revealed that all 54 
animals were infected with the same "exotic" Leishmania species and exhibiting a close phylogenetic 55 
relationship to Leishmania siamensis (syn. Leishmania martiniquensis belonging to the Leishmania 56 
enriettii complex; [7]) identified previously in a patient from Thailand with visceral leishmaniasis [8]. 57 
Conventional diagnosis of cutaneous leishmaniasis relies predominantly on serology and 58 
histological examination of skin biopsy samples. Although histology can be facilitated by 59 
immunohistochemistry, the intracellular amastigotes are difficult to identify, particularly in sections that 60 
contain small numbers of parasites [9,10]. Accordingly, it is not surprising that the sensitive PCR 61 
technology has gained increasing importance as an alternative method to substantiate the histological 62 
diagnosis of cutaneous leishmaniasis. However, PCR performed on histological slides is often 63 
complicated by the fact that DNA extracted from formalin-fixed and paraffin-embedded tissue may be 64 
partially degraded and/or contains components that inhibit PCR [10]. In this context, the quality of the 65 
DNA extracted from such fixed material and the robustness of a particular amplification procedure 66 
determine the diagnostic operating characteristics of a PCR for histological samples. 67 
In the past, several groups [12,13] including ours [5,11] have demonstrated that PCR technology is 68 
well suited for the detection of Leishmania amastigotes in formalin-fixed and paraffin-embedded skin 69 
biopsy samples. However, since none of these studies was able to establish diagnostic sensitivity of 70 
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the tests used, we now elaborated a protocol to compare the performance of PCR, routine histology 71 
and immunohistochemistry for the diagnosis of cutaneous leishmaniasis.  72 
In order to obtain test samples suitable for the development of our PCR protocol, archival skin 73 
biopsy specimens from 9 dogs and 6 horses with confirmed cutaneous leishmaniasis were selected by 74 
searching a data-base with information on cases studied between 2007 and 2015 at the Institute of 75 
Veterinary Pathology, Vetsuisse Faculty, University of Berne (see Table 1). Using our previous 76 
method of PCR-based sequencing of ITS-1, followed by phylogenetic analysis revealed L. infantum in 77 
canine samples (unpublished data), and L. siamensis-related species ([5] and unpublished data) in 78 
equine samples.  79 
Formalin-fixed and paraffin-embedded tissues were sectioned (2 x 4 µm and 1 x 10 µm) and 80 
mounted on glass slides. The 4 µm-thick sections were stained with haematoxylin and eosin (HE) for 81 
histological examination and then subjected to immunohistochemistry using an established protocol 82 
[5]. 83 
The 10 µm-thick sections of individual samples were subjected to DNA extraction according to 84 
Müller et al. [11]. To prepare a defined DNA standard for PCR-based quantification of skin biopsy 85 
material, a Leishmania-negative skin sample was also subjected to DNA preparation by accurately 86 
scraping the tissue off the slide with a disposable sterile scalpel blade. The tissue isolated in this 87 
manner was weighed and then used for DNA extraction. From the extracted DNA, we prepared a 88 
control sample containing DNA equating to 50 µg of tissue per µl, representing the starting 89 
concentration of the alpha-actin-PCR standard dilutions (see below). Prior to quantitative PCR 90 
analysis, the quality of all DNA preparations was assessed [11] in order to exclude issues pertaining to 91 
DNA degradation and residual PCR inhibitors in samples (not shown). 92 
The quantification of skin tissue on histological sections was performed by real-time PCR using a 93 
LightCycler™ 2.0 Instrument (Roche Diagnostics, Basel, Switzerland). Here, PCR primers designed to 94 
an alpha-actin gene sequence, which is conserved for mammals, were employed to allow comparative 95 
quantification of tissues from different mammalian hosts of Leishmania sp. [11,14]. The standard curve 96 
from the alpha-actin–PCR included 4 log units within a linear range (undiluted to 1:1000-diluted control 97 
sample, containing DNA equating to 50 µg to 0.05 µg of tissue per µl; data not shown) that essentially 98 
covered the maximal and minimal concentrations of DNA within the different test samples.  99 
The quantitative assessment of Leishmania in DNA prepared from tissue sections was performed 100 
using a fluorescence resonance energy transfer (FRET) probe-based real-time PCR employing the 101 
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LightCycler™ and corresponding standard software (v.3.5.3). This quantitative PCR amplified a 102 
ribosomal ITS-1 sequence tract that is common to a large variety of species of Leishmania [6,15,16]. 103 
Primers L5.8S and LITSR [15] used for the PCR-amplification of the ITS1 region had been utilised 104 
previously in conventional PCR assays, allowing sensitive and specific detection as well as genetic 105 
characterisation of numerous Leishmania species, including L. siamensis [5,6,15]. The detection of 106 
DNA amplification products was achieved by hybridisation of an ITS-1-specific 5′-LC-Red 640 labelled 107 
LITS1-5LC (5′-ATGGATGACTTGGCTTCCTATTTCGT-3′) detection probe and a 3′-fluorescein 108 
labelled LITS-1-3FL (5′-AACGGCTCACATAACGTGTCG-3′) anchor probe (TIB MOLBIOL, Munich, 109 
Germany). PCR amplification was performed in the LightCycler DNA Master Hybridisation Probes™ 110 
Kit (Roche Diagnostics) containing “Hot-Start” Taq DNA polymerase and dUTP instead of dTTP (see 111 
below). PCR mixes (10 µl volume) were supplemented with MgCl2 to a final concentration of 3 µM and 112 
contained 0.5 µM of each primer plus 0.3 µM of each probe. Any potential carry-over contamination 113 
was removed by adding 0.125 units of UDG (Roche Diagnostics) [17]. For UDG-mediated 114 
decontamination prior to PCR, the reaction mixture was initially incubated for 10 min at 40 °C. This 115 
incubation was followed by an incubation at 95°C fo r 15 min to inactivate UDG, denature the DNA and 116 
activate “Hot-Start” Taq DNA polymerase. Subsequent amplification was conducted for 50 cycles 117 
(denaturation: 95 °C, 20 s; "touch down" annealing:  60 °C to 53 °C including temperature steps of 1 °C  118 
per cycle, 20 s; quantitative assessment of fluorescence signal using the ‘single’ mode with the 119 
channel setting F2/1: 63 °C, 0 s; extension: 72 °C,  20 s; ramp rate for all cycle steps was 20 °C) usi ng 120 
1 µl of individual, undiluted DNA samples. As external standards, samples containing L. infantum 121 
(strain IPZ-229-1-89; [11]) DNA equating to 10'000, 1'000, 100, 10, 1, and 0.1 parasite(s) were 122 
included (data not shown). When tested using serial 1:10 dilutions of DNA from in vitro-cultured L. 123 
infantum promastigotes, the real-time Leishmania-ITS1-PCR had an extremely high analytical 124 
sensitivity in that could detect <0.1 of L. infantum genome equivalents per amplification reaction (not 125 
shown).  126 
The Leishmania-ITS1-PCR and the alpha-actin PCR were used to assess the relative amounts of 127 
Leishmania amastigotes (below referred to as Leishmania densities) in formalin-fixed and paraffin-128 
embedded tissues from archival samples (Table 1). These quantitative PCR assays allowed the 129 
determination of the ratio between Leishmania amastigotes (given as number of cells) and amount of 130 
histological tissue material tested (given as µg tissue). Respective analyses revealed a large variety of 131 
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Leishmania amastigote densities ranging from 0.016 (canine case 9) to 305 (equine case 15) 132 
amastigotes per µg of tissue. 133 
A histological evaluation of all canine and equine cases was conducted prior to PCR analyses (Fig. 134 
1). In all HE-stained sections, cellular infiltrates composed of macrophages, plasma cells and 135 
lymphocytes were present, such that cutaneous leishmaniasis was amongst differential diagnoses 136 
based on histology findings (Fig. 1, panel a). Amastigotes within the macrophages and occasionally in 137 
between collagen fibers thus confirmed leishmaniasis, and were identified in all sections that produced 138 
a moderate to high amount of Leishmania DNA by PCR (cases 7 and 15; Fig. 1, panel a). Amastigotes 139 
were not detected, or were questionable, in cases with a low intensity of infection (case 9; Fig. 1, 140 
panel a). Immunohistochemical analysis of tissues from cases 9, 7 and 15 that had previously been 141 
scored by quantitative Leishmania-ITS1-PCR as weak (0.016 amastogotes per µg tissue), moderate 142 
(72.5 amastogotes per µg tissue), and strong (305 amastigotes per µg tissue; see Table 1) positive 143 
(cf. Fig. 1, panel b). Here, unambiguous microscopic detection of intracellular Leishmania amastigotes 144 
in HE-stained sections was restricted to high- and medium-positive sections. In sections with low 145 
numbers of amastigotes, however, immunohistochemistry was necessary to achieve the detection of 146 
parasitised tissue by careful microscopic inspection of the entire section, as demonstrated, for 147 
example, for case 9. Here, Leishmania-ITS1-PCR-negative canine and equine sections were 148 
characterised by a lympho-histiocytic infiltrate consistent with leishmaniasis cases and were included 149 
as reference samples to avoid misinterpretation of nuclear debris as Leishmania amastigotes.   150 
In conclusion, we describe a novel real-time PCR which allows a highly sensitive detection of 151 
various (if not all) species pf the genus Leishmania. This Leishmania-ITS1-PCR exhibits an excellent 152 
diagnostic sensitivity when applied to the testing of paraffin-embedded skin biopsy samples. The 153 
Leishmania-ITS1-PCR achieved a very similar diagnostic sensitivity as immunohistochemistry. In 154 
contrast to immunohistochemistry, however, the PCR allowed an unambiguous interpretation of the 155 
results, even in cutaneous leishmaniasis cases with extremely low numbers of amastigotes. This 156 
comparative evaluation of the ITS1-PCR exemplifies the importance of PCR-based technology to 157 
complement the histological diagnosis of cutaneous leishmaniasis. The data presented here also 158 
emphasise the suitability of the present quantitative PCR assay for retrospective epidemiological and 159 
genetic studies, particularly in situations where only archival histological specimens from cutaneous 160 
leishmaniasis cases are available. 161 
 162 
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Fig. 1. Haematoxylin and eosin-stained (panel a) and immunostained (panel b) skin biopsy sections 226 
from two dogs and one horse with histological findings that were consistent with cutaneous 227 
leishmaniasis (lympho-histiocytic and plasmacytic infiltrate). Arrows indicate areas of parasitised 228 
tissue. Cases 9, 7 and 15 were scored by quantitative Leishmania-ITS1-PCR as weak-, moderate- or 229 
strong-positive for Leishmania (see Table 1). In addition, Leishmania-negative sections characterised 230 
by lympho-histiocytic and/or plasmacytic infiltrates of an etiology other than leishmaniasis were 231 
chosen as negative controls (neg.). Equine case 15 and the corresponding negative control are 232 
indicated in italics. Magnifications: 400x (images of panels a and b) and 1000x (enlarged inserts 233 
presented for the immuno-stained sections of cases 9, 7 and 15).  234 
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Table 1 
Quantitative real-time PCR-based determination of Leishmania amastigote densities in formalin-fixed 
and paraffin-embedded skin biopsy samples from dogs and horses. 
 
aSample no. bTotal no. amastigotes cTissue (inυg µg) dNo. amastigotes per µg tissue 
        
1 0.7 41.7 0.017 
2 3344 20.5 163 
3 4.3 1.7 2.5 
4 12.2 0.7 17.4 
5 0.7 35.1 0.020 
6 4.6 46.4 0.099 
7 2744 37.8 72.5 
8 1.6 1.5 1.1 
9 0.3 18.4 0.016 
10 863 4.9 176.2 
11 55.3 1.3 42.5 
12 68.2 0.5 136 
13 8695 42.4 205 
14 21.9 5.2 4.2 
15 457 1.5 305 
 
a
 Samples 1-9, canine biopsies positive for L. infantum; samples 10-15, positive for L. siamensis 
b
 Total number of Leishmania sp. amastigotes in samples as assessed by quantitative Leishmania-
ITS1-PCR  
c
 Total amount of tissue in samples as assessed by quantitative alpha-actin-PCR  
d
 Density of Leishmania sp. amastigotes in samples  
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Highlights 
• This report describes a real-time PCR approach for the quantification of Leishmania 
amastigotes in paraffin-embedded skin biopsy samples.  
• In contrast to (immuno-) histology, the novel Leishmania-PCR allowed to unambiguously 
diagnose even cases of cutaneous leishmaniasis with an extremely low amastigote load. 
• Our results highlighted the importance of PCR supporting routine histology to diagnose 
cutaneous leishmaniasis. 
 
